O	O	0	1	A	A	B-NP	DT	O	3	NMOD	O
O	O	2	10	critical	critical	I-NP	JJ	O	3	NMOD	O
O	O	11	15	role	role	I-NP	NN	O	0	ROOT	O
O	O	16	18	of	of	B-PP	IN	O	3	NMOD	O
O	O	19	22	the	the	B-NP	DT	O	10	NMOD	O
T1	B-Protein	23	26	p75	p75	I-NP	NN	B-protein	10	NMOD	B-protein
T1	I-Protein	27	32	tumor	tumor	I-NP	NN	I-protein	10	NMOD	I-protein
T1	I-Protein	33	41	necrosis	necrosis	I-NP	NN	I-protein	10	NMOD	I-protein
T1	I-Protein	42	48	factor	factor	I-NP	NN	I-protein	10	NMOD	I-protein
T1	I-Protein	49	57	receptor	receptor	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	58	59	(	(	O	(	O	15	DEP	O
T2	B-Protein	59	65	p75TNF	p75TNF	B-NP	NN	B-protein	14	NMOD	B-protein
T2	I-Protein	65	66	-	-	B-NP	HYPH	I-protein	14	P	I-protein
T2	I-Protein	66	67	R	R	I-NP	NN	I-protein	15	DEP	I-protein
O	O	67	68	)	)	O	)	O	10	NMOD	O
O	O	69	71	in	in	B-PP	IN	O	3	NMOD	O
O	O	72	77	organ	organ	B-NP	NN	O	18	NMOD	O
O	O	78	90	inflammation	inflammation	I-NP	NN	O	16	PMOD	O
O	O	91	102	independent	independent	B-ADJP	JJ	O	18	NMOD	O
O	O	103	105	of	of	B-PP	IN	O	19	AMOD	O
O	O	106	109	TNF	TNF	B-NP	NN	B-protein	30	NMOD	B-protein
O	O	109	110	,	,	O	,	O	30	P	O
T3	B-Protein	111	122	lymphotoxin	lymphotoxin	B-NP	NN	B-protein	24	NMOD	B-protein
T3	I-Protein	123	128	alpha	alpha	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	128	129	,	,	O	,	O	30	P	O
O	O	130	132	or	or	O	CC	O	30	NMOD	O
O	O	133	136	the	the	B-NP	DT	O	30	NMOD	O
T4	B-Protein	137	143	p55TNF	p55TNF	I-NP	NN	B-protein	30	NMOD	B-protein
T4	I-Protein	143	144	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T4	I-Protein	144	145	R	R	I-NP	NN	I-protein	20	PMOD	I-protein
O	O	145	146	.	.	O	.	O	3	P	O

O	O	148	155	Despite	Despite	B-PP	IN	O	53	VMOD	O
O	O	156	168	overwhelming	overwhelming	B-NP	JJ	O	3	NMOD	O
O	O	169	177	evidence	evidence	I-NP	NN	O	53	SUB	O
O	O	178	182	that	that	B-SBAR	IN	O	3	NMOD	O
O	O	183	191	enhanced	enhance	B-NP	VBN	O	6	NMOD	O
O	O	192	202	production	production	I-NP	NN	O	19	SUB	O
O	O	203	205	of	of	B-PP	IN	O	6	NMOD	O
O	O	206	209	the	the	B-NP	DT	O	13	NMOD	O
T5	B-Protein	210	213	p75	p75	I-NP	NN	B-protein	13	NMOD	B-protein
T5	I-Protein	214	219	tumor	tumor	I-NP	NN	I-protein	13	NMOD	I-protein
T5	I-Protein	220	228	necrosis	necrosis	I-NP	NN	I-protein	13	NMOD	I-protein
T5	I-Protein	229	235	factor	factor	I-NP	NN	I-protein	13	NMOD	I-protein
T5	I-Protein	236	244	receptor	receptor	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	245	246	(	(	O	(	O	18	DEP	O
T6	B-Protein	246	252	p75TNF	p75TNF	B-NP	NN	B-protein	17	NMOD	B-protein
T6	I-Protein	252	253	-	-	B-NP	HYPH	O	17	P	O
T6	I-Protein	253	254	R	R	I-NP	NN	O	18	DEP	O
O	O	254	255	)	)	O	)	O	13	NMOD	O
O	O	256	267	accompanies	accompany	B-VP	VBZ	O	4	SBAR	O
O	O	268	279	development	development	B-NP	NN	O	49	NMOD	O
O	O	280	282	of	of	B-PP	IN	O	20	NMOD	O
O	O	283	291	specific	specific	B-NP	JJ	O	24	AMOD	O
O	O	292	297	human	human	I-NP	JJ	O	24	AMOD	O
O	O	298	310	inflammatory	inflammatory	I-NP	JJ	O	25	NMOD	O
O	O	311	322	pathologies	pathology	I-NP	NNS	O	21	PMOD	O
O	O	323	327	such	such	B-PP	JJ	O	27	PMOD	O
O	O	328	330	as	as	I-PP	IN	O	25	NMOD	O
O	O	331	336	multi	multi	B-NP	AFX	O	31	NMOD	O
O	O	336	337	-	-	I-NP	HYPH	O	31	NMOD	O
O	O	337	342	organ	organ	I-NP	NN	O	31	NMOD	O
O	O	343	350	failure	failure	I-NP	NN	O	27	PMOD	O
O	O	351	357	during	during	B-PP	IN	O	20	NMOD	O
O	O	358	364	sepsis	sepsis	B-NP	NN	O	32	PMOD	O
O	O	364	365	,	,	O	,	O	49	P	O
O	O	366	378	inflammatory	inflammatory	B-NP	JJ	O	37	NMOD	O
O	O	379	384	liver	liver	I-NP	NN	O	37	NMOD	O
O	O	385	392	disease	disease	I-NP	NN	O	49	NMOD	O
O	O	392	393	,	,	O	,	O	49	P	O
O	O	394	406	pancreatitis	pancreatitis	B-NP	NN	O	46	NMOD	O
O	O	406	407	,	,	O	,	O	46	P	O
O	O	408	419	respiratory	respiratory	B-NP	JJ	O	43	NMOD	O
O	O	420	428	distress	distress	I-NP	NN	O	43	NMOD	O
O	O	429	437	syndrome	syndrome	I-NP	NN	O	46	NMOD	O
O	O	437	438	,	,	O	,	O	46	P	O
O	O	439	441	or	or	O	CC	O	46	NMOD	O
O	O	442	446	AIDS	AIDS	B-NP	NNP	O	49	NMOD	O
O	O	446	447	,	,	O	,	O	49	P	O
O	O	448	451	the	the	B-NP	DT	O	49	NMOD	O
O	O	452	460	function	function	I-NP	NN	O	19	OBJ	O
O	O	461	463	of	of	B-PP	IN	O	49	NMOD	O
O	O	464	468	this	this	B-NP	DT	O	52	NMOD	O
O	O	469	477	receptor	receptor	I-NP	NN	O	50	PMOD	O
O	O	478	485	remains	remain	B-VP	VBZ	O	0	ROOT	O
O	O	486	492	poorly	poorly	B-VP	RB	O	55	VMOD	O
O	O	493	500	defined	define	I-VP	VBN	O	53	VC	O
O	O	501	503	in	in	B-ADVP	FW	O	55	VMOD	O
O	O	504	508	vivo	vivo	I-ADVP	FW	O	56	AMOD	O
O	O	508	509	.	.	O	.	O	53	P	O

O	O	510	512	We	We	B-NP	PRP	O	2	SUB	O
O	O	513	517	show	show	B-VP	VBP	O	0	ROOT	O
O	O	518	522	here	here	B-ADVP	RB	O	2	VMOD	O
O	O	523	527	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	528	530	at	at	B-PP	IN	O	22	VMOD	O
O	O	531	537	levels	level	B-NP	NNS	O	5	PMOD	O
O	O	538	546	relevant	relevant	B-ADJP	JJ	O	6	NMOD	O
O	O	547	549	to	to	B-PP	TO	O	7	AMOD	O
O	O	550	555	human	human	B-NP	JJ	O	10	NMOD	O
O	O	556	563	disease	disease	I-NP	NN	O	8	PMOD	O
O	O	563	564	,	,	O	,	O	22	P	O
O	O	565	575	production	production	B-NP	NN	O	22	SUB	O
O	O	576	578	of	of	B-PP	IN	O	12	NMOD	O
O	O	579	582	the	the	B-NP	DT	O	18	NMOD	O
O	O	583	588	human	human	I-NP	JJ	B-protein	18	NMOD	B-protein
T7	B-Protein	589	595	p75TNF	p75TNF	I-NP	NN	I-protein	18	NMOD	I-protein
T7	I-Protein	595	596	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T7	I-Protein	596	597	R	R	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	598	600	in	in	B-PP	IN	O	12	NMOD	O
O	O	601	611	transgenic	transgenic	B-NP	JJ	O	21	NMOD	O
O	O	612	616	mice	mouse	I-NP	NNS	O	19	PMOD	O
O	O	617	624	results	result	B-VP	VBZ	O	4	SBAR	O
O	O	625	627	in	in	B-PP	IN	O	22	VMOD	O
O	O	628	629	a	a	B-NP	DT	O	27	NMOD	O
O	O	630	636	severe	severe	I-NP	JJ	O	27	NMOD	O
O	O	637	649	inflammatory	inflammatory	I-NP	JJ	O	27	NMOD	O
O	O	650	658	syndrome	syndrome	I-NP	NN	O	23	PMOD	O
O	O	659	668	involving	involve	B-VP	VBG	O	27	NMOD	O
O	O	669	675	mainly	mainly	B-ADVP	RB	O	28	VMOD	O
O	O	676	679	the	the	B-NP	DT	O	31	NMOD	O
O	O	680	688	pancreas	pancreas	I-NP	NN	O	38	NMOD	O
O	O	688	689	,	,	O	,	O	38	P	O
O	O	690	695	liver	liver	B-NP	NN	O	38	NMOD	O
O	O	695	696	,	,	O	,	O	38	P	O
O	O	697	703	kidney	kidney	B-NP	NN	O	38	NMOD	O
O	O	703	704	,	,	O	,	O	38	P	O
O	O	705	708	and	and	O	CC	O	38	NMOD	O
O	O	709	713	lung	lung	B-NP	NN	O	28	OBJ	O
O	O	713	714	,	,	O	,	O	22	P	O
O	O	715	718	and	and	O	CC	O	22	VMOD	O
O	O	719	732	characterized	characterize	B-VP	VBN	O	22	VMOD	O
O	O	733	735	by	by	B-PP	IN	O	41	VMOD	O
O	O	736	750	constitutively	constitutively	B-NP	RB	O	44	AMOD	O
O	O	751	760	increased	increase	I-NP	VBN	O	48	NMOD	O
T11	B-Entity	761	763	NF	NF	I-NP	NN	B-protein	48	NMOD	B-protein
T11	I-Entity	763	764	-	-	I-NP	HYPH	I-protein	48	NMOD	I-protein
T11	I-Entity	764	770	kappaB	kappaB	I-NP	NN	I-protein	48	NMOD	I-protein
O	O	771	779	activity	activity	I-NP	NN	O	42	PMOD	O
O	O	780	782	in	in	B-PP	IN	O	48	NMOD	O
O	O	783	786	the	the	B-NP	DT	O	55	NMOD	O
O	O	787	797	peripheral	peripheral	I-NP	JJ	B-cell_type	55	NMOD	B-cell_type
O	O	798	803	blood	blood	I-NP	NN	I-cell_type	55	NMOD	I-cell_type
O	O	804	815	mononuclear	mononuclear	I-NP	JJ	I-cell_type	55	NMOD	I-cell_type
O	O	816	820	cell	cell	I-NP	NN	I-cell_type	55	NMOD	I-cell_type
O	O	821	832	compartment	compartment	I-NP	NN	O	49	PMOD	O
O	O	832	833	.	.	O	.	O	2	P	O

O	O	834	838	This	This	B-NP	DT	O	2	NMOD	O
O	O	839	846	process	process	I-NP	NN	O	3	SUB	O
O	O	847	849	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	850	855	shown	show	I-VP	VBN	O	3	VC	O
O	O	856	858	to	to	I-VP	TO	O	6	VMOD	O
O	O	859	865	evolve	evolve	I-VP	VB	O	4	VMOD	O
O	O	866	879	independently	independently	B-ADVP	RB	O	6	VMOD	O
O	O	880	882	of	of	B-PP	IN	O	7	AMOD	O
O	O	883	886	the	the	B-NP	DT	O	10	NMOD	O
O	O	887	895	presence	presence	I-NP	NN	O	8	PMOD	O
O	O	896	898	of	of	B-PP	IN	O	10	NMOD	O
O	O	899	902	TNF	TNF	B-NP	NN	B-protein	11	PMOD	B-protein
O	O	902	903	,	,	O	,	O	7	AMOD	O
T8	B-Protein	904	915	lymphotoxin	lymphotoxin	B-NP	NN	B-protein	15	NMOD	B-protein
T8	I-Protein	916	921	alpha	alpha	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	921	922	,	,	O	,	O	21	P	O
O	O	923	925	or	or	O	CC	O	21	NMOD	O
O	O	926	929	the	the	B-NP	DT	O	19	NMOD	O
T9	B-Protein	930	936	p55TNF	p55TNF	I-NP	NN	B-protein	21	NMOD	B-protein
T9	I-Protein	936	937	-	-	B-NP	HYPH	O	21	NMOD	O
T9	I-Protein	937	938	R	R	I-NP	NN	B-protein	13	SBAR	B-protein
O	O	938	939	,	,	O	,	O	21	P	O
O	O	940	948	although	although	B-SBAR	IN	O	21	VMOD	O
O	O	949	961	coexpression	coexpression	B-NP	NN	O	30	SUB	O
O	O	962	964	of	of	B-PP	IN	O	24	NMOD	O
O	O	965	966	a	a	B-NP	DT	O	29	NMOD	O
T12	B-Entity	967	972	human	human	I-NP	JJ	B-DNA	29	NMOD	B-DNA
T12	I-Entity	973	976	TNF	TNF	I-NP	NN	I-DNA	29	NMOD	I-DNA
T12	I-Entity	977	986	transgene	transgene	I-NP	NN	I-DNA	25	PMOD	I-DNA
O	O	987	998	accelerated	accelerate	B-VP	VBD	O	23	SBAR	O
O	O	999	1008	pathology	pathology	B-NP	NN	O	30	OBJ	O
O	O	1008	1009	.	.	O	.	O	3	P	O

O	O	1010	1015	These	These	B-NP	DT	O	2	NMOD	O
O	O	1016	1023	results	result	I-NP	NNS	O	3	SUB	O
O	O	1024	1033	establish	establish	B-VP	VBP	O	0	ROOT	O
O	O	1034	1036	an	an	B-NP	DT	O	6	NMOD	O
O	O	1037	1048	independent	independent	I-NP	JJ	O	6	NMOD	O
O	O	1049	1053	role	role	I-NP	NN	O	3	OBJ	O
O	O	1054	1057	for	for	B-PP	IN	O	6	NMOD	O
O	O	1058	1066	enhanced	enhance	B-NP	VBN	O	12	NMOD	O
T10	B-Protein	1067	1073	p75TNF	p75TNF	I-NP	NN	B-protein	12	NMOD	B-protein
T10	I-Protein	1073	1074	-	-	B-NP	HYPH	O	12	NMOD	O
T10	I-Protein	1074	1075	R	R	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	1076	1086	production	production	I-NP	NN	O	7	PMOD	O
O	O	1087	1089	in	in	B-PP	IN	O	12	NMOD	O
O	O	1090	1093	the	the	B-NP	DT	O	15	NMOD	O
O	O	1094	1106	pathogenesis	pathogenesis	I-NP	NN	O	13	PMOD	O
O	O	1107	1109	of	of	B-PP	IN	O	15	NMOD	O
O	O	1110	1122	inflammatory	inflammatory	B-NP	JJ	O	18	NMOD	O
O	O	1123	1130	disease	disease	I-NP	NN	O	16	PMOD	O
O	O	1131	1134	and	and	O	CC	O	3	VMOD	O
O	O	1135	1144	implicate	implicate	B-VP	VBP	O	3	VMOD	O
O	O	1145	1148	the	the	B-NP	DT	O	23	NMOD	O
O	O	1149	1155	direct	direct	I-NP	JJ	O	23	NMOD	O
O	O	1156	1167	involvement	involvement	I-NP	NN	O	20	OBJ	O
O	O	1168	1170	of	of	B-PP	IN	O	23	NMOD	O
O	O	1171	1175	this	this	B-NP	DT	O	26	NMOD	O
O	O	1176	1184	receptor	receptor	I-NP	NN	O	24	PMOD	O
O	O	1185	1187	in	in	B-PP	IN	O	23	NMOD	O
O	O	1188	1189	a	a	B-NP	DT	O	30	NMOD	O
O	O	1190	1194	wide	wide	I-NP	JJ	O	30	NMOD	O
O	O	1195	1200	range	range	I-NP	NN	O	27	PMOD	O
O	O	1201	1203	of	of	B-PP	IN	O	30	NMOD	O
O	O	1204	1209	human	human	B-NP	JJ	O	34	NMOD	O
O	O	1210	1222	inflammatory	inflammatory	I-NP	JJ	O	34	NMOD	O
O	O	1223	1234	pathologies	pathology	I-NP	NNS	O	31	PMOD	O
O	O	1234	1235	.	.	O	.	O	3	P	O
